Active substance
Lactated ringer
- SFDA 14
- US price lines 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| COMPOUND SODIUM LACTATE INFUSION | Solution · Intravenous use | 1 Bag | SAR 6.90 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid | |
| COMPOUND SODIUM LACTATE INFUSION | Solution · Intravenous use | 1 Bag | SAR 6.90 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid | |
| LACTATED RINGERS INJECTION | Solution for injection · Intravenous use | 20 Bottle | SAR 138.00 | Generic · Prescription | AL RAZI PHARMA INDUSTRIES | Valid | |
| LACTATED RINGER'S INJ | Solution for injection · Intravenous use | 1 Bag | SAR 5.10 | Generic · Prescription | BAXTER | Withdrawn by MAH · Not Marketed | |
| LACTATED RINGER'S INJ | Solution for injection · Intravenous use | 1 Bag | SAR 6.55 | Generic · Prescription | BAXTER | Withdrawn by MAH · Not Marketed | |
| LACTATED RINGER'S INJ | Solution for injection · Intravenous use | 1 Bag | SAR 5.00 | Generic · Prescription | BAXTER | Withdrawn by MAH · Not Marketed | |
| LACTATED RINGERS | Solution · Intravenous use | 1 Bag | SAR 7.30 | Generic · Prescription | McGAW | Invalid · Not Marketed | |
| LACTATED RINGERS | Solution · Intravenous use | 1 Bag | SAR 7.05 | Generic · Prescription | McGAW | Invalid · Not Marketed | |
| LACTATED RINGERS INJ | Solution for injection · Intravenous use | 1 Bottle | SAR 9.10 | Generic · Prescription | HOSPIRA INC | Withdrawn by MAH · Not Marketed | |
| LACTATED RINGERS INJ | Solution for injection · Intravenous use | 1 Bottle | SAR 9.50 | Generic · Prescription | HOSPIRA INC | Withdrawn by MAH · Not Marketed | |
| LACTATED RINGERS INJ | Solution for injection · Intravenous use | 1 Bag | SAR 4.70 | Generic · Prescription | HOSPIRA INC | Withdrawn by MAH · Not Marketed | |
| LACTATED RINGERS INJ | Solution for injection · Intravenous use | 1 Bag | SAR 5.70 | Generic · Prescription | QATAR PHARMA | Withdrawn by regulatory authority · Not Marketed | |
| LACTATED RINGERS INJ. | Solution for injection · Intravenous use | 1 Bottle | SAR 4.80 | Generic · Prescription | QATAR PHARMA | Withdrawn by regulatory authority · Not Marketed | |
| RINGER LACTATE 500ML | Solution · Intravenous use | 1 Bottle | SAR 19.60 | Generic · Prescription | PFRIMMER | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ACUTE KIDNEY INJURY (AKI); ACUTE PANCREATITIS; ANESTHESIA-SUPPORTIVE AGENTS/ FLUID RESUSCITATION (UNCONTROLLED BLEEDING); BACTRIAL INFECTIONS OF THE GASTROINTESTINAL TRACT - VIBRIO CHOLERAE; BURN MANAGEMENT; CENTRAL DIABETES INSIPIDUS; DIARRHEA; FLUIDS AND VOLUME EXPANDERS-RESUSCITATION; INFECTIOUS DIARRHEA-SUPPORTIVE TREATMENT; Septic Shock; VIRAL GASTROENTERITIS
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | LACTATED RINGERS 1,000 ML | $0.00384 | per ML | 23 Sep 2026 |
| US NADAC | LACTATED RINGERS INJECTION | $0.00384 | per ML | 23 Sep 2026 |
| US NADAC | LACTATED RINGERS INJECTION | $0.00201 | per ML | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.